Evidence map›Paper›PMID 40490748›Full record

ArticleJournal of nanobiotechnology2025

Antitumor/anti-inflammatory effects/tissue healing as an all-in-one therapeutic strategy for nasopharyngeal carcinoma.

Fan Ni, Hanxin Lv, Liting Lin, Yiqun Zhang, Yang Qiao, Xiaopei Zhang, Zengyang Li, Xianwen Wang, Xingliang Dai, Jun Dong

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of nanobiotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Fan Ni *Department of Otolaryngology Head and Neck Surgery, The Second Affiliated Hospital of Soochow University, Suzhou, 215004, P. R. China.
Hanxin Lv *Department of Otolaryngology Head and Neck Surgery, The Second Affiliated Hospital of Soochow University, Suzhou, 215004, P. R. China.
Liting Lin *School of Biomedical Engineering, Anhui Medical University, Hefei, 230032, P. R. China.
Yiqun ZhangSchool of Biomedical Engineering, Anhui Medical University, Hefei, 230032, P. R. China.
Yang QiaoDepartment of Neurosurgery, The First Affiliated Hospital of Anhui Medical University, Hefei, 230001, Anhui, P. R. China.
Xiaopei ZhangDepartment of Neurosurgery, The Second Affiliated Hospital of Soochow University, Suzhou, 215004, P. R. China.
Zengyang LiDepartment of Neurosurgery, The Second Affiliated Hospital of Soochow University, Suzhou, 215004, P. R. China.
Xianwen WangSchool of Biomedical Engineering, Anhui Medical University, Hefei, 230032, P. R. China. xianwenwang@ahmu.edu.cn.
Xingliang DaiDepartment of Neurosurgery, The First Affiliated Hospital of Anhui Medical University, Hefei, 230001, Anhui, P. R. China. daixingliang@ahmu.edu.cn.
Jun DongDepartment of Neurosurgery, The Second Affiliated Hospital of Soochow University, Suzhou, 215004, P. R. China. dongjun@suda.edu.cn.

Funding

and the Health Research Program of Anhui AHWJ2023A30007Anhui Province Excellent Research and Innovation Team Project 2024AH010013Anhui Provincial Natural Science Foundation 2408085Y016General Project of the National Natural Science Foundation of China 82473127National Natural Science Foundation of China 52202343National Natural Science Foundation of China 82170572the Anhui Province Higher Education Scientific Research Project 2024AH050818the Excellent Youth of Natural Science Research Projects in Anhui Province Universities 2023AH030060the Research Fund of Anhui Institute of Translational Medicine 2023zhyx-C19
6 · The paper itself

Abstract

Nasopharyngeal carcinoma (NPC) is one of the most prevalent cancers in the head and neck region. The development of innovative therapies that are effective at eliminating tumors while minimizing damage to surrounding normal tissues due to postoperative complications is crucial. To solve this problem, a gelatin-sodium alginate (Gel-SA) hydrogel containing bismuth selenide nanosheets (Bi

Indexed as

Anti-Inflammatory AgentsAntineoplastic AgentsNasopharyngeal CarcinomaNasopharyngeal NeoplasmsAlginatesAnimalsApoptosisBismuthCell Line, TumorFerroptosisGelatinHumansHydrogelsMiceOxidative StressPhotochemotherapyAlginatesAnti-Inflammatory AgentsAntineoplastic AgentsBismuthGelatinHydrogelsApoptosisFerroptosisNanozymesPhotodynamic therapyPhotothermal therapyPostoperative anti-inflammatoryTissue healing

Identifiers

PMID40490748
PMCPMC12147296

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.